Maze Therapeutics, Inc. Common Stock
€22.38
EUR
Last updated on --.
24h volume401.87K
24h highest23.0394 EUR
24h lowest21.8612 EUR
24h Price movement-1.21%


MAZE recent prices
24 Hours
-1.21%-€0.2752
30 days
-0.48%-€0.1075
60 days
-10.98%-€2.740
90 days
-43.35%-€17.00
Key data
Previous close22.6610 EUR
Market cap1.19B EUR
Volume401.87K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.9006 EUR
Net income (FY)-105.39M EUR
Revenue (FY)17.20M EUR
Last report dateMay 12, 2026
About Maze Therapeutics, Inc. Common Stock
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)141.00
Revenue per employee (FY)121.99K EUR
Net income per employee (FY)-747.42K EUR
Listed onNasdaq
MAZE conversion tables
| 0.5 MAZE | 11.19 EUR |
| 1 MAZE | 22.38 EUR |
| 5 MAZE | 111.92 EUR |
| 10 MAZE | 223.85 EUR |
| 0.5 EUR | 0.022336 MAZE |
| 1 EUR | 0.044671 MAZE |
| 5 EUR | 0.22336 MAZE |
| 10 EUR | 0.44671 MAZE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
MAZE is trading at €22.38, -1.21% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MAZE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MAZE is currently trading at €22.38, -1.21% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MAZE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MAZE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MAZE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MAZE's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Maze Therapeutics, Inc. Common Stock's market cap is currently 1.19B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume401.87K
24h highest23.0394 EUR
24h lowest21.8612 EUR
24h Price movement-1.21%


Start trade with MAZE Perpetual
Sign up to trade
















